Back
Seres Therapeutics Vs. Cellectar Biosciences Industry Stock Comparison
Sell
35
MCRB
Seres Therapeutics
Last Price:
0.92
Seasonality Move:
-14.51%
Sell
44
CLRB
Cellectar Biosciences
Last Price:
2.05
Seasonality Move:
-16.85%
Sell
35
Seres Therapeutics (MCRB)
is a Sell
Is Seres Therapeutics a Buy, Sell or Hold?
- The current Seres Therapeutics [MCRB] share price is $0.92. The Score for MCRB is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- MCRB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Cellectar Biosciences (CLRB)
is a Sell
Is Cellectar Biosciences a Buy, Sell or Hold?
- The current Cellectar Biosciences [CLRB] share price is $2.04. The Score for CLRB is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- CLRB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MCRB Stock Price Chart
What is Seres Therapeutics's stock price today?
-
The Seres Therapeutics share price today is $0.92
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MCRB is experiencing slight selling pressure.
CLRB Stock Price Chart
What is Cellectar Biosciences's stock price today?
-
The Cellectar Biosciences share price today is $2.04
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLRB is experiencing buying pressure, which is a positive indicator for future bullish movement.
MCRB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 45.95 | Sell |
| Chaikin Money Flow: | -775790 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.84 - 1.06) | Sell |
| Bollinger Bands (100): | (0.78 - 1.14) | Sell |
CLRB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 46.45 | Sell |
| Chaikin Money Flow: | 166076 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.02 - 2.18) | Sell |
| Bollinger Bands (100): | (2.04 - 3) | Sell |
MCRB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.02 | Sell |
| 20-day SMA: | 0.98 | Sell |
| 50-day SMA: | 1.02 | Sell |
| 200-day SMA: | 0.99 | Sell |
| 8-day EMA: | 0.98 | Sell |
| 20-day EMA: | 0.98 | Sell |
| 50-day EMA: | 0.98 | Sell |
| 200-day EMA: | 1.3 | Sell |
CLRB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.02 | Buy |
| 20-day SMA: | 2.08 | Sell |
| 50-day SMA: | 2.12 | Sell |
| 200-day SMA: | 2.97 | Sell |
| 8-day EMA: | 2.01 | Buy |
| 20-day EMA: | 2.06 | Sell |
| 50-day EMA: | 2.19 | Sell |
| 200-day EMA: | 2.63 | Sell |
Seres Therapeutics Earnings Growth & MCRB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.49 per share, a decrease next quarter of $0.14 per share, an increase this year of $0.27 per share, and an increase next year of $0.17 per share.
Cellectar Biosciences Earnings Growth & CLRB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, an increase next quarter of $0.02 per share, an increase this year of $1.08 per share, and an increase next year of $1.21 per share.
Seres Therapeutics Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cellectar Biosciences Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||